Telus slashed its dividend 40% effective immediately, the most severe capital reallocation by a North American incumbent telco since BCE's 2008 restructuring. New CEO Victor Dodig, who took the helm May 1st from Darren Entwistle's 26-year run, announced the cut alongside Q2 earnings that showed a $122M net loss and confirmed the company will sell its healthcare subsidiary and international tower assets. The annual dividend drops from $1.4644 to $0.8786 per share, freeing roughly $1.1B in annual cash flow currently earmarked for debt reduction.

Telus is not improvising. The move mirrors the European template Vodafone executed in 2023 (dividend halved, £7B asset sales) and BT's ongoing £3B cost program. All three face identical pressure: mobile revenue plateauing below 2% annual growth, fiber and 5G buildouts requiring $4-6B in sustained capex, and leverage ratios above 3.0x net debt to EBITDA that spook credit desks. Telus closed Q2 with $26.3B in net debt and an EBITDA multiple of 3.1x, acceptable for a utility but uncomfortable for a growth story that has underperformed the S&P 500 by 47% over three years.

Dodig's calculus is cold: yield investors already fled when the share price dropped 38% from its 2022 peak, so cutting the dividend punishes ghosts. What remains are allocators who want optionality, and optionality requires balance-sheet room. The healthcare unit, Telus Health, generated $2.1B in revenue last year but operates at low margins and distracts from the core wireless-and-fiber duopoly Telus shares with Rogers and BCE. A clean sale at 8-10x EBITDA would retire $2-3B in debt and move the leverage ratio toward 2.5x, the threshold where investment-grade spreads tighten and buyback conversations begin.

The international tower portfolio is harder to price but easier to justify. Telus owns stakes in infrastructure across 13 markets outside Canada, a legacy of Entwistle's diversification ambitions. Those assets have minimal strategic overlap with the domestic network and carry execution risk Dodig clearly does not want. Selling them into the current infrastructure-fund bid environment—where tower multiples still command 20-25x EBITDA despite rate volatility—would add another $1-2B to the war chest. The combined moves position Telus to hit $23B net debt by end of 2025, materially below the $28B trajectory analysts modeled before the cuts.

Allocators should watch three events over the next six months: Telus Health buyer emergence (likely a PE consortium or US health-tech consolidator), tower-asset bids (American Tower and Brookfield both active), and whether Dodig uses the 2025 AGM to formalize a three-year capital-return framework. If he does, it will include modest buybacks and a dividend floor, not growth.

The tell is not the dividend cut. The tell is Dodig announcing it 90 days into tenure, before institutional memory could argue for gradualism. He is importing the discipline he learned restructuring CIBC's balance sheet, and he is doing it without the courtesy of a roadshow.